Enhanced bone regeneration by gelatin-β-tricalcium phosphate composites enabling controlled release of bFGF

Journal of Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 8, 2014, Pages 604-611

  Omata, Kazuhiko ^a   Matsuno, Tomonori ^a   Asano, Kazunari ^a,b   Hashimoto, Yoshiya ^c   Tabata, Yasuhiko ^b   Satoh, Tazuko ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c OSAKA DENTAL UNIVERSITY   (Japan)

Author keywords

BFGF; Bone regeneration; Composite; Controlled release; Gelatin; tricalcium phosphate

Indexed keywords

BIODEGRADATION; BONE; COMPUTERIZED TOMOGRAPHY; DEFECTS; SCAFFOLDS (BIOLOGY); TRANSMISSION CONTROL PROTOCOL;

BASIC FIBROBLAST GROWTH FACTOR; BFGF; BONE REGENERATION; CELL SCAFFOLD; CONTROLLED RELEASE; GELATIN; GELATIN SPONGE; SEGMENTAL BONE DEFECT; TRI-CALCIUM PHOSPHATES; Β-TRICALCIUM PHOSPHATE;

CELL CULTURE;

CALCIUM PHOSPHATE; EOSIN; FIBROBLAST GROWTH FACTOR 2; GELATIN; GELATIN SPONGE; HEMATOXYLIN; TISSUE SCAFFOLD; BETA-TRICALCIUM PHOSPHATE; DELAYED RELEASE FORMULATION;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADATION; BONE DEFECT; BONE REGENERATION; COMPOSITE MATERIAL; CONTROLLED STUDY; IMPLANTATION; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RABBIT; ULNA; ANIMAL; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HUMAN; MALE; PATHOLOGY; RADIOGRAPHY; SCANNING ELECTRON MICROSCOPY; SWINE; TIME;

ANIMALS; BONE REGENERATION; CALCIUM PHOSPHATES; DELAYED-ACTION PREPARATIONS; FIBROBLAST GROWTH FACTOR 2; GELATIN; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; RABBITS; SUS SCROFA; TIME FACTORS; ULNA; X-RAY MICROTOMOGRAPHY;

EID: 84905027984     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1553     Document Type: Article

References (32)

1. Canalis E, Centrella M, McCarthy T. 1988; Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81: 1572-1577.
2. Habraken WJ, Wolke JG, Mikos AG et al. 2008; PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics. J Biomater Sci Polym Ed 19: 1171-1188.
3. Hokugo A, Kubo Y, Takahashi Y et al. 2004; Prefabrication of vascularized bone graft using guided bone regeneration. Tissue Eng 10: 978-986.
4. Hokugo A, Ozeki M, Kawakami O et al. 2005; Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 11: 1224-1233.
5. Ichioka S, Ohura N, Nakatsuka T. 2005; The positive experience of using a growth factor product on deep wounds with exposed bone. J Wound Care 14: 105-109.
6. Ignatius AA, Ohnmacht M, Claes LE et al. 2001; A composite polymer/tricalcium phosphate membrane for guided bone regeneration in maxillofacial surgery. J Biomed Mater Res 58: 564-569.
7. Jeon O, Kang SW, Lim HW et al. 2006; Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 27: 1598-1607.
8. Kawaguchi H, Kurokawa T, Hanada K et al. 1994; Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135: 774-781.
9. Kilian O, Wenisch S, Karnati S et al. 2008; Observations on the microvasculature of bone defects filled with biodegradable nanoparticulate hydroxyapatite. Biomaterials 29: 3429-3437.
10. Kinoshita Y, Matsuo M, Todoki K et al. 2008; Alveolar bone regeneration using absorbable poly(l-lactide-co-ε-caprolactone)/β-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor. Int J Oral Maxillofac Surg 37: 275-281.
11. Kitamura M, Nakashima K, Kowashi Y et al. 2008; Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. PLoS One 2: e2611.
12. Komaki H, Tanaka T, Chazono M et al. 2006; Repair of segmental bone defects in rabbit tibiae using a complex of β-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 27: 5118-5126.
13. Kurokawa I, Hayami J, Kita Y. 2003; A therapy-resistant chronic leg ulcer treated successfully with topical basic fibroblast growth factor. J Int Med Res 31: 149-151.
14. Lu J, Descamps M, Dejou J et al. 2002; The biodegradation mechanism of calcium phosphate biomaterials in bone. J Biomed Mater Res 63: 408-412.
15. Marui A, Tabata Y, Kojima S et al. 2007; A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor, using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J 71: 1181-1186.
16. Matsuno T, Nakamura T, Kuremoto K et al. 2006; Development of β-tricalcium phosphate/collagen sponge composite for bone tissue regeneration. Dent Mater J 25: 138-144.
17. Matsuno T, Hashimoto Y, Omata K et al. 2008; Preparation of injectable3D-formed β-tricalcium phosphate bead/alginate composite for bone tissue engineering. Dent Mater J 27: 827-834.
18. Nakahara T, Nakamura T, Kobayashi E et al. 2003; Novel approach to regeneration of periodontal tissues based on in situ tissue engineering: effects of controlled release of basic fibroblast growth factor from a sandwich membrane. Tissue Eng 9: 153-162.
19. Ogose A, Hotta T, Kawashima H et al. 2005; Comparison of hydroxyapatite and β-tricalcium phosphate as bone substitutes after excision of bone tumors. J Biomed Mater Res B Appl Biomater 72: 94-101.
20. Petite H, Viateau V, Bensaid W et al. 2000; Tissue-engineered bone regeneration. Nat Biotechnol 18: 959-963.
21. Pri-Chen S, Pitaru S, Lokiec F et al. 1998; Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23: 111-117.
22. Schnettler R, Alt V, Dingeldein E et al. 2003; Bone ingrowth in bFGF-coated hydroxyapatite ceramic implants. Biomaterials 24: 4603-4608.
23. Sone T, Tamada T, Jo Y et al. 2004; Analysis of three-dimensional microarchitecture and degree of mineralization in bone metastases from prostate cancer using synchrotron microcomputed tomography. Bone 35: 432-438.
24. Tabata Y, Yamada K, Miyamoto S et al. 1998; Bone regeneration of basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19: 807-815.
25. Tabata Y, Nagano A, Ikada Y. 1999; Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5: 127-138.
26. Takahashi Y, Yamamoto M, Tabata Y. 2005; Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 26: 4856-4865.
27. Walsh WR, Langdown AJ, Auld JW et al. 2008; Effect of low intensity pulsed ultrasound on healing of an ulna defect filled with a bone graft substitute. J Biomed Mater Res B Appl Biomater 86B: 74-81.
28. Weiland AJ, Phillips TW, Randolph MA. 1984; Bone grafts: a radiologic, histologic, and biomechanical model comparing autografts, allografts, and free vascularized bone grafts. Plast Reconstr Surg 74: 368-379.
29. Yamada K, Tabata Y, Yamamoto K et al. 1997; Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 86: 871-875.
30. Yamamoto M, Takahashi Y, Tabata Y. 2006; Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12: 1305-1311.
31. Yaszemski MJ, Payne RG, Hayes WC et al. 1996; Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17: 175-185.
32. Yokozeki H, Hayashi T, Nakagawa T et al. 1998; Influence of surface microstructure on the reaction of the active ceramics in vivo. J Mater Sci Mater Med 9: 381-384.